Enveric Biosciences, Inc. (ENVB)
1.445
-0.02
(-1.03%)
USD |
NASDAQ |
Sep 11, 16:00
1.445
0.00 (0.00%)
After-Hours: 16:39
Enveric Biosciences Gross Profit (TTM) : -0.1539M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1539M |
| March 31, 2026 | -0.1571M |
| December 31, 2025 | -0.2009M |
| September 30, 2025 | -0.2439M |
| June 30, 2025 | -0.2883M |
| March 31, 2025 | -0.3331M |
| December 31, 2024 | -0.3375M |
| September 30, 2024 | -0.3397M |
| June 30, 2024 | -0.3507M |
| March 31, 2024 | -0.3803M |
| December 31, 2023 | -0.4082M |
| September 30, 2023 | -0.414M |
| June 30, 2023 | -0.4392M |
| March 31, 2023 | -0.4104M |
| December 31, 2022 | -0.4007M |
| September 30, 2022 | -0.5076M |
| June 30, 2022 | -0.5602M |
| March 31, 2022 | -0.6487M |
| December 31, 2021 | -0.6816M |
| September 30, 2021 | -0.4844M |
| June 30, 2021 | -0.3107M |
| March 31, 2021 | -0.1366M |
| September 30, 2020 | 1.150M |
| June 30, 2020 | 2.487M |
| March 31, 2020 | 4.306M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.885M |
| September 30, 2019 | 6.005M |
| June 30, 2019 | 6.376M |
| March 31, 2019 | 6.137M |
| December 31, 2018 | 6.080M |
| September 30, 2018 | 5.966M |
| June 30, 2018 | 6.003M |
| March 31, 2018 | 5.930M |
| December 31, 2017 | 7.021M |
| September 30, 2017 | 7.294M |
| June 30, 2017 | 6.735M |
| March 31, 2017 | 6.644M |
| December 31, 2016 | 7.067M |
| September 30, 2016 | 8.827M |
| June 30, 2016 | 9.070M |
| March 31, 2016 | 8.629M |
| December 31, 2015 | 5.593M |
| September 30, 2015 | 2.405M |
| June 30, 2015 | 0.9746M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 19.36M |
| Impact BioMedical, Inc. | -1.532M |
| ANI Pharmaceuticals, Inc. | 505.18M |
| Corcept Therapeutics, Inc. | 816.73M |
| Veru, Inc. | -0.113M |